Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001005286-25-000041
Filing Date
2025-02-27
Accepted
2025-02-27 16:05:59
Documents
5
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A lfcr-specialcommitteeproxya.htm DEF 14A 249406
2 lfcrbiomedicalinc_vxprxy001.jpg GRAPHIC 129808
3 lfcrbiomedicalinc_vxprxy002.jpg GRAPHIC 144564
4 lfcrbiomedicalinc_vxprxy003.jpg GRAPHIC 132244
5 lfcrbiomedicalinc_vxprxy004.jpg GRAPHIC 146709
  Complete submission text file 0001005286-25-000041.txt   1012999
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: DEF 14A | Act: 34 | File No.: 000-27446 | Film No.: 25678687
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)